Amgen putting $200M into plant it bought from Pfizer

Amgen ($AMGN) is going to sink $200 million into the plant in Ireland it acquired last year from Pfizer ($PFE). The company says it will erect an 11,700-square-meter extension, add a production plant and expand the warehouse at the site in Dun Laoghaire. About 100 new jobs will be needed when the project is complete late next year. "We are very pleased to expand our investment in Ireland," said Martin VanTrieste, senior vice-president of quality at Amgen. "As we expand internationally, Dun Laoghaire will enhance our global production capability." he said. Story | More



Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.